These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 23455711)
1. Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles. Zhang N; Francis KP; Prakash A; Ansaldi D Nat Med; 2013 Apr; 19(4):500-5. PubMed ID: 23455711 [TBL] [Abstract][Full Text] [Related]
2. [Human serum albumin modified under oxidative/halogenative stress enhances luminol-dependent chemiluminescence of human neutrophils]. Mikhal'chik EV; Smolina NV; Astamirova TC; Gorudko IV; Grigor'eva DV; Ivanov VA; Sokolov AV; Kostevich VA; Cherenkevich SN; Panasenko OM Biofizika; 2013; 58(4):681-9. PubMed ID: 24455888 [TBL] [Abstract][Full Text] [Related]
5. A myeloperoxidase-specific assay based upon bromide-dependent chemiluminescence of luminol. Haqqani AS; Sandhu JK; Birnboim HC Anal Biochem; 1999 Aug; 273(1):126-32. PubMed ID: 10452808 [TBL] [Abstract][Full Text] [Related]
6. Bioluminescence Imaging of Inflammation in Vivo Based on Bioluminescence and Fluorescence Resonance Energy Transfer Using Nanobubble Ultrasound Contrast Agent. Liu R; Tang J; Xu Y; Dai Z ACS Nano; 2019 May; 13(5):5124-5132. PubMed ID: 31059237 [TBL] [Abstract][Full Text] [Related]
7. In vivo imaging method to distinguish acute and chronic inflammation. Tseng JC; Kung AL J Vis Exp; 2013 Aug; (78):. PubMed ID: 23978851 [TBL] [Abstract][Full Text] [Related]
8. Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reaction. Pekoe G; Van Dyke K; Peden D; Mengoli H; English D Agents Actions; 1982 Jul; 12(3):371-6. PubMed ID: 6291348 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence. Pekoe G; Van Dyke K; Mengoli H; Peden D; English D Agents Actions; 1982 Apr; 12(1-2):232-8. PubMed ID: 6282074 [TBL] [Abstract][Full Text] [Related]
10. A FeS Liu X; Fan Q; Zhang X; Li M; Huan Y; Ma P; Song D; Fei Q Talanta; 2022 Apr; 240():123171. PubMed ID: 34954617 [TBL] [Abstract][Full Text] [Related]
11. Syzygium aromaticum aqueous extract inhibits human neutrophils myeloperoxidase and protects mice from LPS-induced lung inflammation. Chniguir A; Zioud F; Marzaioli V; El-Benna J; Bachoual R Pharm Biol; 2019 Dec; 57(1):56-64. PubMed ID: 30707845 [TBL] [Abstract][Full Text] [Related]
12. Analysis of luminol-dependent chemiluminescence from granule depleted neutrophil cytoplasts reveals two different light-emitting mechanisms. Dahlgren C J Biolumin Chemilumin; 1988; 2(1):25-33. PubMed ID: 2850722 [TBL] [Abstract][Full Text] [Related]
13. Using Naturally Occurring Bioluminescent Enzymes to Track Specific Cell Populations. Shrestha TB; Basel MT Methods Mol Biol; 2020; 2126():13-20. PubMed ID: 32112375 [TBL] [Abstract][Full Text] [Related]
14. Graphene-based chemiluminescence resonance energy transfer for homogeneous immunoassay. Lee JS; Joung HA; Kim MG; Park CB ACS Nano; 2012 Apr; 6(4):2978-83. PubMed ID: 22417160 [TBL] [Abstract][Full Text] [Related]
15. Comparison between luminol- and lucigenindependent chemiluminescence of polymorphonuclear leukocytes. Aniansson H; Stendahl O; Dahlgren C Acta Pathol Microbiol Immunol Scand C; 1984 Dec; 92(6):357-61. PubMed ID: 6098130 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. von Leitner EC; Klinke A; Atzler D; Slocum JL; Lund N; Kielstein JT; Maas R; Schmidt-Haupt R; Pekarova M; Hellwinkel O; Tsikas D; D'Alecy LG; Lau D; Willems S; Kubala L; Ehmke H; Meinertz T; Blankenberg S; Schwedhelm E; Gadegbeku CA; Böger RH; Baldus S; Sydow K Circulation; 2011 Dec; 124(24):2735-45. PubMed ID: 22082678 [TBL] [Abstract][Full Text] [Related]
17. Luminol-enhanced chemiluminescence induced in peripheral blood-derived human phagocytes: obligatory requirement of myeloperoxidase exocytosis by monocytes. Albrecht D; Jungi TW J Leukoc Biol; 1993 Oct; 54(4):300-6. PubMed ID: 8409752 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice. Tiyerili V; Camara B; Becher MU; Schrickel JW; Lütjohann D; Mollenhauer M; Baldus S; Nickenig G; Andrié RP Int J Cardiol; 2016 Feb; 204():29-36. PubMed ID: 26655530 [TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase exerts anti-tumor activity in glioma after radiotherapy. Ali M; Fulci G; Grigalavicius M; Pulli B; Li A; Wojtkiewicz GR; Wang C; Hsieh KL; Linnoila JJ; Theodossiou TA; Chen JW Neoplasia; 2022 Apr; 26():100779. PubMed ID: 35247801 [TBL] [Abstract][Full Text] [Related]
20. An enhanced chemiluminescence resonance energy transfer system based on target recycling G-guadruplexes/hemin DNAzyme catalysis and its application in ultrasensitive detection of DNA. Chen J; Huang Y; Vdovenko M; Sakharov IY; Su G; Zhao S Talanta; 2015 Jun; 138():59-63. PubMed ID: 25863372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]